Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C20H27NO3 |
| Molecular Weight | 329.4333 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=CC=CC=C1CNCCC2=CC(OC)=C(C)C(C)=C2OC
InChI
InChIKey=VDAUMFACIMNTDA-UHFFFAOYSA-N
InChI=1S/C20H27NO3/c1-14-15(2)20(24-5)16(12-19(14)23-4)10-11-21-13-17-8-6-7-9-18(17)22-3/h6-9,12,21H,10-11,13H2,1-5H3
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Prevalence of use and acute toxicity associated with the use of NBOMe drugs. | 2015-02 |
|
| High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens. | 2014-04 |
|
| Analytical characterization of three hallucinogenic N-(2-methoxy)benzyl derivatives of the 2C-series of phenethylamine drugs. | 2013-08 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
25G-NBOMe
Created by
admin on Wed Apr 02 11:29:23 GMT 2025 , Edited by admin on Wed Apr 02 11:29:23 GMT 2025
|
PRIMARY | |||
|
1354632-65-7
Created by
admin on Wed Apr 02 11:29:23 GMT 2025 , Edited by admin on Wed Apr 02 11:29:23 GMT 2025
|
PRIMARY | |||
|
DTXSID401152547
Created by
admin on Wed Apr 02 11:29:23 GMT 2025 , Edited by admin on Wed Apr 02 11:29:23 GMT 2025
|
PRIMARY | |||
|
118796428
Created by
admin on Wed Apr 02 11:29:23 GMT 2025 , Edited by admin on Wed Apr 02 11:29:23 GMT 2025
|
PRIMARY | |||
|
87KXL8U1L5
Created by
admin on Wed Apr 02 11:29:23 GMT 2025 , Edited by admin on Wed Apr 02 11:29:23 GMT 2025
|
PRIMARY |
ACTIVE MOIETY
